A possible link between TIMP-1 induction and response to infliximab.
Derer
S
S
Waetzig
G H
GH
Seegert
D
D
Nikolaus
S
S
Schreiber
S
S
Rosenstiel
P
P
D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D017209:Apoptosis / Q000187:drug effects; D003424:Crohn Disease / Q000188:drug therapy* / Q000378:metabolism; D006801:Humans; D000069285:Infliximab; D019715:Tissue Inhibitor of Metalloproteinase-1 / Q000378:metabolism*; D016211:Transforming Growth Factor alpha / Q000037:antagonists & inhibitors / Q000378:metabolism
D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D019715:Tissue Inhibitor of Metalloproteinase-1; D016211:Transforming Growth Factor alpha; D000069285:Infliximab